Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Pain and Headache Reports
Published in: Current Pain and Headache Reports 3/2012

01-06-2012 | Migraine Headache (F Taylor, Section Editor)

Why HURT? A Review of Clinical Instruments for Headache Management

Authors: Dawn C. Buse, C. Mark Sollars, Timothy J. Steiner, Rigmor H. Jensen, Mohammed A. Al Jumah, Richard B. Lipton

Published in: Current Pain and Headache Reports | Issue 3/2012

Login to get access

Abstract

The Global Campaign against Headache, directed by the non-governmental organization Lifting The Burden (LTB) in official relations with the World Health Organization (WHO), aspires to reduce the global burden of headache. Ultimately this calls for improvements in headache management, largely in primary care, where most people with headache receive medical care. In support, LTB is developing a range of headache management aids for primary care. Presently, no single instrument covers the range of assessment and decision-making necessary for successful headache management, and few make the important link between assessment and clinical advice. Expressly to fill this gap, LTB has developed a new instrument: the Headache Under-Response to Treatment (HURT) Questionnaire, an eight-item, self-administered questionnaire addressing headache frequency, disability, medication use and effect, perceptions of headache “control” and knowledge of diagnosis. This instrument is intended not only to evaluate current headache outcomes and assess the need for and response to treatment, but also to provide guidance on appropriate actions towards treatment optimization. The first draft of the HURT was created by an expert consensus group, meeting at WHO headquarters in Geneva, Switzerland. The final version came about through multiple refinements following psychometric testing. Assessment of clinical utility is ongoing in multiple countries.
Literature
1.
Stovner LJ, Hagen K, Jensen R, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007;27:193–210.PubMedCrossRef
2.
•• World Health Organization and Lifting The Burden: Atlas of headache disorders and resources in the world. Geneva, WHO; 2011. The Atlas of Headache Disorders presents data on prevalence, burden, treatment, costs, education, and unmet needs in headache worldwide acquired through in a questionnaire survey of neurologists, general practitioners and patients’ representatives from 101 countries, performed from October 2006 until March 2009. Additional relevant data from epidemiological studies were compiled through a systematic review and supplemented by data gathered in population-based studies undertaken within the global campaign.
3.
Silberstein SD, Olesen J, Bousser M-G, et al. The international classification of headache disorders: 2nd Edition. Cephalalgia. 2004;24 suppl 1:1–160.
4.
5.
Steiner TJ. World Headache Alliance: lifting the burden: the global campaign against headache. Lancet Neurol. 2004;3:204–5.PubMedCrossRef
6.
Steiner TJ. Lifting The Burden: the global campaign to reduce the burden of headache worldwide. J Headache Pain. 2005;6:373–7.PubMedCrossRef
7.
• Steiner TJ, Birbeck GL, Jensen R, et al. Lifting the Burden: the first 7 years. J Headache Pain. 2010;11:451–5. This article describes the history, conception, guiding principles, goals, and accomplishments of the Lifting the Burden Campaign from 2003 to 2010 as well as works in progress and future plans..PubMedCrossRef
8.
Lipton RB, Bigal ME, Amatniek JC, Stewart WF. Tools for diagnosing migraine and measuring its severity. Headache. 2004;44:387–98.PubMedCrossRef
9.
Steiner TJ. National and international action plans for improving headache diagnosis. In: Olesen J, editor. Classification and diagnosis of headache disorders. Oxford: Oxford University Press; 2004. p. 265–71.
10.
11.
12.
Steiner TJ, Paemeleire K, Jensen R, et al. European principles of management of common headache disorders in primary care. J Headache Pain. 2007;8:S3–47.PubMedCrossRef
13.
Dodick DW. Clinical clues and clinical rules: primary versus secondary headache. Adv Stud Med. 2003;3:S550–5.
14.
Maizels M, Houle T. Results of screening with the brief headache screen compared with a modified ID Migraine. Headache. 2008;48:385–94.PubMedCrossRef
15.
Lipton RB, Dodick D, Sadovsky R, et al. A self-administered screener for migraine in primary care: the ID Migraine validation study. Neurology. 2003;61:375–82.PubMed
16.
Maizels M, Wolfe WJ. An expert system for headache diagnosis: the Computerized Headache Assessment tool (CHAT). Headache. 2008;48:72–8.PubMedCrossRef
17.
• Jensen R, Tassorelli C, Rossi P, et al. A basic diagnostic headache diary (BDHD) is well accepted and useful in the diagnosis of headache: a multicentre European and Latin American study. Cephalalgia. 2011;31:1549–60. Researchers investigated the BDHD at headache centers throughout Europe and Latin America. When used in conjunction with clinical interview, the BDHD provides health care professionals with information complete for diagnosis significantly more frequently than interview alone..PubMedCrossRef
18.
Lipton RB, Bigal ME, Ashina S, et al. Cutaneous allodynia in the migraine population. Ann Neurol. 2008;63:148–58.PubMedCrossRef
19.
Andrasik F. Migraine and quality of life: psychological considerations. J Headache Pain. 2001;2:S1–9.CrossRef
20.
Andrasik F. Psychophysiological disorders: headache as a case in point. In: Andrasik F, editor. Comprehensive handbook of personality and psychopathology, volume two: adult psychopathology. Hoboken: Wiley; 2006. p. 409–22.
21.
• Buse DC, Rupnow MF, Lipton RB. Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life. Mayo Clin Proc. 2009;84:422–35. This article reviews multiple domains of assessment necessary for comprehensive headache care. It introduces and describes the development and psychometric data for the MPQ-5 and MIBS-4 and reviews empirical and guidelines supported pharmacologic and nonpharmacologic approaches to migraine management. Also, several strategies are recommended to improve office visit communication with the intention of improving migraine impact assessment and treatment planning..PubMed
22.
Leonardi M, Steiner TJ, Scher AT, Lipton RB. The global burden of migraine: measuring disability in headache disorders with WHO’s Classification of Functioning, Disability, and Health (ICF). J Headache Pain. 2005;6:429–40.PubMedCrossRef
23.
Bussone G, Usai S, Grazzi L, et al. Disability and quality of life in different primary headaches: results from Italian studies. Neurol Sci. 2004;25:S105–7.PubMedCrossRef
24.
Solomon GD, Skobieranda FG, Gragg LA. Quality of life and well-being of headache patients: measurement by the medical outcomes study instrument. Headache. 1993;33:351–8.PubMedCrossRef
25.
Bigal ME, Rapoport AM, Lipton RB, et al. Assessment of migraine disability using the Migraine Disability Assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine. Headache. 2003;43:336–42.PubMedCrossRef
26.
Bigal ME, Serrano D, Reed M, Lipton RB. Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment. Neurology. 2008;71:559–66.PubMedCrossRef
27.
Buse DC, Manack A, Serrano D, et al. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry. 2010;81:428–32.PubMedCrossRef
28.
Lipton RB, Liberman JN, Kolodner KB, et al. Migraine headache disability and health-related quality-of-life: a population-based case–control study from England. Cephalalgia. 2003;23:441–50.PubMedCrossRef
29.
Ware Jr JE, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220–33.PubMedCrossRef
30.
Ware Jr JE, Sherbourne CD. The MOS 36-item short-form survey (SF-36): I. Conceptual framework and item selection. Med Care. 1996;30:473–83.CrossRef
31.
Solomon GD. Evolution of the measurement of quality of life in migraine. Neurology. 1997;48:S10–5.PubMed
32.
Martin BC, Pathak DS, Sharfman MI, et al. Validity and reliability of the migraine-specific quality of life questionnaire (MSQ Version 2.1). Headache. 2000;40:204–15.PubMedCrossRef
33.
Wagner TH, Patrick DL, Galer BS, Berzon RA. A new instrument to assess the long term quality of life effects from migraine: development and psychometric testing of the MSQOL. Headache. 1996;36:484–92.PubMedCrossRef
34.
El Hasnaoui A, Vray M, Richard A, MIGSEV Group, et al. Assessing the severity of migraine: development of the MIGSEV scale. Headache. 2003;43:628–35.PubMedCrossRef
35.
Stewart WF, Lipton RB, Simon D, et al. Reliability of an illness severity measure for headache in a population sample of migraine sufferers. Cephalalgia. 1998;18:44–51.PubMedCrossRef
36.
Blumenfeld AM, Varon SF, Wilcox TK, et al. Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia. 2011;31:301–15.PubMedCrossRef
37.
Stewart WF, Lipton RB, Kolodner KB, et al. Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers. Pain. 2000;88:41–52.PubMedCrossRef
38.
Hershey AD, Powers SW, Vockell ALB, et al. Development of a questionnaire to assess disability of migraines in children. Neurology. 2001;57:2034–9.PubMed
39.
Steiner TJ. The HALT and HART indices. J Headache Pain. 2007;8:S22–5.
40.
Kosinski M, Bayliss MS, Bjorner JB, et al. A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res. 2003;12:963–74.PubMedCrossRef
41.
Pathak DS, Chisolm DJ, Weis KA. Functional Assessment in Migraine (FAIM) questionnaire: development of an instrument based upon the WHO’s International Classification of Functioning, Disability, and Health. Value Health. 2005;8:591–600.PubMedCrossRef
42.
Cramer JA, Silberstein SD, Winner P. Development and validation of the Headache Needs Assessment (HANA) survey. Headache. 2001;41:402–9.PubMedCrossRef
43.
Dahlof CGH, Dimenäs E. Migraine patients experience poorer subjective well-being/quality of life even between attacks. Cephalalgia. 1995;15:31–6.PubMedCrossRef
44.
Jacobson GP, Ramadan NM, Aggarwal SK, Newman CK. The Henry ford Hospital Disability Inventory (HDI). Neurology. 1994;44:837–42.PubMed
45.
Jacobson GP, Ramadan NM, Norris L, Newman CW. Headache disability inventory (HDI): short-term test-retest reliability and spouse perceptions. Headache. 1995;35:534–9.PubMedCrossRef
46.
Buse DC, Bigal ME, Rupnow MFT, et al. The Migraine Interictal Burden Scale (MIBS): results of a population-based validation study. Headache. 2007;47:778.
47.
48.
Breslau N, Davis GC, Andreski P. Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res. 1991;37:11–23.PubMedCrossRef
49.
Blanchard EB, Andrasik F, Evans DD, et al. Behavioral treatment of 250 chronic headache patients: a clinical replication series. Behav Ther. 1985;16:308–27.CrossRef
50.
Jacob RG, Turner SM, Szekely BC, Eidelman BH. Predicting outcome of relaxation therapy in headaches: the role of “depression.”. Behav Ther. 1983;14:457–65.CrossRef
51.
Holroyd KA, Holm JE, Hursey KG, et al. Recurrent vascular headache: home-based behavioral treatment vs. abortive pharmacological treatment. J Consult Clin Psychol. 1988;56:218–23.PubMedCrossRef
52.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Press; 2000.
53.
Spitzer RL, Kroenke K, Williams JBW, and the Patient Health Questionnaire Primary Care Study Group. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. JAMA. 1999;282:1737–44.PubMedCrossRef
54.
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606–13.PubMedCrossRef
55.
Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166:1092–7.PubMedCrossRef
56.
Kroenke K, Spitzer RL, Williams JB, Löwe B. An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics. 2009;50:613–21.PubMed
57.
Beck AT, Steer RA, Garbing MG. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev. 1988;8:77–100.CrossRef
58.
Beck AT, Steer RA. Manual for the beck depression inventory. San Antonio: Psychological Corporation; 1993.
59.
Beck AT, Epstein N, Brown G, Steer R. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56:893–7.PubMedCrossRef
60.
Weathers FW, Litz BT, Herman DS, et al. The PTSD Checklist (PCL): reliability, validity, and diagnostic utility. Proceedings of the Annual Conference of the International Society for Traumatic Stress Studies. San Antonio, Texas; October 25, 1993.
61.
Blanchard EB, Jones-Alexander J, Buckley TC, Forneris CA. Psychometric properties of the PTSD Checklist (PCL). Behav Res Ther. 1996;34:669–73.PubMedCrossRef
62.
Prins A, Ouimette P, Kimerling R, et al. The primary care PTSD screen (PC–PTSD): development and operating characteristics. Primary Care Psychiatry. 2004;9:9–14.CrossRef
63.
Weathers FW, Huska JA, Keane TM. PCL-C for DSM-IV. Boston: National Center for PTSD Behavioral Science Division; 1991.
64.
Saper JR, Lake AE. Borderline personality disorder and the chronic headache patient: review and management recommendations. Headache. 2002;42:663–74.PubMedCrossRef
65.
Hathaway SR, McKinley JC. The Minnesota multiphasic personality inventory manual. New York: Psychological Corporation; 1983.
66.
Werder DS, Sargent JD, Coyne L. MMPI profiles of headache patients using self regulation to control headache activity. Headache. 1981;21:164–9.PubMedCrossRef
67.
Nicholson RA, Houle TT, Rhudy JL, Norton PJ. Psychological risk factors in headache. Headache. 2007;47:413–26.PubMed
68.
Heath RL, Saliba M, Mahmassani O, et al. Locus of control moderates the relationship between headache pain and depression. J Headache Pain. 2008;9:301–8.PubMedCrossRef
69.
Martin NJ, Holroyd KA, Penzien DB. The headache-specific locus of control scale: adaptation to recurrent headaches. Headache. 1990;30:729–34.PubMedCrossRef
70.
VandeCreek L, O’ Donnell F. Psychometric characteristics of the Headache-Specific Locus of Control Scale. Headache. 1992;32:239–41.PubMedCrossRef
71.
Bandura A. Social foundations of thought and action. A social cognitive theory. Englewood Cliffs: Prentice Hall; 1986.
72.
French DJ, Holroyd KA, Pinell C, et al. Perceived self efficacy and headache-related disability. Headache. 2000;40:647–56.PubMedCrossRef
73.
Marlowe N. Stressful events, appraisal, coping, and recurrent headache. J Clin Psychol. 1986;54:247–56.CrossRef
74.
Nicholson RA, Hursey KG, Nash J. Moderators and mediators of behavioral treatment for headache. Headache. 2005;45:513–9.PubMedCrossRef
75.
Smith T, Nicholson R. Are changes in cognitive and emotional factors important in improving in headache impact and quality of life? Headache. 2006;46:878.
76.
Bond D, Dirge K, Rubingh C, et al. Impact of a self-help intervention on performance of headache management behaviors: a self-efficacy approach. Internet J Allied Health Sci Pract. 2004;2:1–12.
77.
Nicholson RA, Nash J, Andrasik F. A self-administered behavioral intervention using tailored messages for migraine. Headache. 2005;45:1124–39.PubMedCrossRef
78.
Ellis A. Reason and emotion in psychotherapy. New York: Lyle Stewart; 1962.
79.
Holroyd KA, Drew JB, Cottrell CK, et al. Impaired functioning and quality of life in severe migraine: the role of catastrophizing and associated symptoms. Cephalalgia. 2007;27:1156–65.PubMedCrossRef
80.
Sullivan MJL, Bishop SR, Pivik J. The Pain Catastrophizing Scale: development and validation. Psychol Assess. 1995;7:524–32.CrossRef
81.
• Buse DC, Andrasik F, Sollars CM. Headaches. In: Andrasik F, Goodie J, Peterson A, editors. Biopsychosocial assessment in clinical health psychology: a handbook. New York: Guilford Press; 2012. This chapter reviews the utility and psychometric properties of a range of instruments useful for headache clinical practice and research in multiple domains..
82.
Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the quality standards subcommittee of the American academy of neurology. Neurology. 2000;55:754–62.PubMed
83.
Matchar DB, Harpole L, Samsa GP, et al. The headache management trial: a randomized study of coordinated care. Headache. 2008;48:1294–310.PubMedCrossRef
84.
Andrasik F, Grazzi L, Usai S, et al. Non-pharmacological approaches to treating chronic migraine with medication overuse. Neurol Sci. 2009;30 Suppl 1:S89–93.PubMedCrossRef
85.
Grazzi L, Andrasik F, Usai S, Bussone G. Treatment of chronic migraine with medication overuse: is drug withdrawal crucial? Neurol Sci. 2009;30 Suppl 1:S85–8.PubMedCrossRef
86.
Silberstein SD. Chronic daily headache. J Am Osteopath Assoc. 2005;105 Suppl 2:S23–9.
87.
Dowson AJ, Tepper SJ, Baos V, et al. Identifying patients who require a change in their current acute migraine treatment: the Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire. Curr Med Res Opin. 2004;20:1125–35.PubMedCrossRef
88.
• Lipton RB, Kolodner K, Bigal ME, et al. Validity and reliability of the migraine-treatment optimization questionnaire. Cephalalgia. 2009;29:751–9. This article describes the development and psychometric evaluation of the MTOQ-5. It also reviews treatment optimization and related clinical concepts..PubMedCrossRef
89.
Revicki DA, Kimel M, Beusterien K, et al. Validation of the revised patient perception of migraine questionnaire: measuring satisfaction with acute migraine treatment. Headache. 2006;46:240–52.PubMedCrossRef
90.
Chatterton ML, Lofland JH, Shechter A, et al. Reliability and validity of the migraine therapy assessment questionnaire. Headache. 2002;42:1006–15.PubMedCrossRef
91.
Lipton RB, Serrano D, Buse DC, et al. The Migraine Prevention Questionnaire (MPQ): development and validation. Headache. 2007;47:770–1.CrossRef
92.
Buse DC, Pearlman SH, Reed ML, et al. Opioid use and dependence among persons with migraine: results of the AMPP study. Headache. 2012;52:18–36.PubMedCrossRef
93.
Radat F, Irachabal S, Lafittau M, et al. Construction of a medication dependence questionnaire in headache patients (MDQ-H) validation of the French version. Headache. 2006;46:233–9.PubMedCrossRef
94.
Akbik H, Butler SF, Budman SH, et al. Validation and clinical application of the Screener and Opioid Assessment for Patients with Pain (SOAPP). J Pain Symptom Manage. 2006;32:287–93.PubMedCrossRef
95.
Butler SF, Budman SH, Fernandez KC, et al. Development and validation of the current opioid misuse measure. Pain. 2007;130:144–56.PubMedCrossRef
96.
Buse DC, Steiner TJ, Serrano D, et al. Psychometric validity of the lifting the burden Headache Under-Response to Treatment (HURT) Index: a new instrument developed to improve management of headache. Headache. 2010;50:S42–3.CrossRef
97.
Buse DC, Steiner TJ, Serrano D, et al. The Headache Under-Response to Treatment (HURT) index: an outcome measure to improve management of headache, especially in primary care. Neurology. 2010;74 Suppl 2:A323.
98.
Al Jumah M, Al Khathaami A, Kojan S, et al. HURT Index in primary care: reliability and impact on headache management and patients’ satisfaction. J Neurol. 2010;257:S98.CrossRef
Metadata
Title
Why HURT? A Review of Clinical Instruments for Headache Management
Authors
Dawn C. Buse
C. Mark Sollars
Timothy J. Steiner
Rigmor H. Jensen
Mohammed A. Al Jumah
Richard B. Lipton
Publication date
01-06-2012
Publisher
Current Science Inc.
Published in
Current Pain and Headache Reports / Issue 3/2012
Print ISSN: 1531-3433
Electronic ISSN: 1534-3081
DOI
https://doi.org/10.1007/s11916-012-0263-1

Other articles of this Issue 3/2012

Current Pain and Headache Reports 3/2012 Go to the issue

Neuropathic Pain (R Raja, Section editor)

Quantitative Sensory Testing of Neuropathic Pain Patients: Potential Mechanistic and Therapeutic Implications

Migraine Headache (F Taylor, Section Editor)

The Bowel and Migraine: Update on Celiac Disease and Irritable Bowel Syndrome

Migraine Headache (F Taylor, Section Editor)

Sinus Venous Stenosis–Associated Idiopathic Intracranial Hypertension Without Papilledema as a Powerful Risk Factor for Progression and Refractoriness of Headache

Migraine Headache (F Taylor, Section Editor)

Migrainous Infarction: Aspects on Risk Factors and Therapy

Neuropathic Pain (R Raja, Section editor)

Epidemiology of Neuropathic Pain and Its Impact on Quality of Life

Neuropathic Pain (R Raja, Section editor)

Spinal Cord Injury Pain: Mechanisms and Management